News and Announcements
OncoSil Medical CE Mark Update
- Published October 13, 2015 1:32PM UTC
- Publisher Wholesale Investor
- Categories Company Updates
12th October 2015, ASX Announcement
OnoSil Medical Limited (ASX: OSL) (OncoSil Medical, the Company) is pleased to provide the following update on its Conformité Européenne (CE) Mark application for the Company’s OncoSilTM localised radiation treatment for cancer.
As previously advised (ASX announcement, 9 September 2015), OncoSil Medical was granted a Fast Track review by the European regulator to assess its CE Mark application for OcoSilTM in pancreatic and primary liver cancer (HCC).
OncoSil Medical now advises that the Fast Track Face-To-Face review phase has been completed, and it now awaits the final outcome of the review as the Notified Body continues to its assessment over the coming weeks. The Compnay was pleased with the review meeting and anticipates that the Notified Body will make a decision in respect of the CE Mark for OncoSilTM in November.
To read the full announcement, please click here.
Company Updates
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Where’s the beef? Blackstone just answered the AI question.
In 1984, a fast food ad asked a question that became a catchphrase. Where’s the beef? Jon Gray, President of Blackstone, used that line this month in front of global LPs. It is the question every capital allocator is asking about AI. Trillions of dollars are going into chips, data centres and power. That is […]
The Best of Both Worlds: How Omnique Fund is Rewiring Real World Assets via Tokenisation
For decades, the playbook for Australia’s wholesale investors has remained relatively unchanged: pick between the slow-moving, illiquid reliability of tangible assets like property and gold, or chase the frictionless, high-velocity liquidity of public equity and digital markets. But as macroeconomic volatility spikes and a structural housing deficit reshapes private debt demand, sophisticated investors are demanding […]
Backed By Leading Investment Groups and Family Offices
